MetLife, Inc.

(New York Stock Exchange)
Back to all articles
Bullish +55

MetLife announces USD 3 billion buyback for MetLife stock

Earnings report Share buyback AI-generated analysis

πŸ“ˆ MetLife adjusted earnings rose 15 percent to USD 1.6 billion in Q2 2026, with EPS up 20 percent year over year.

πŸ’° The company authorized a new USD 3 billion share repurchase program on October 9, 2026.

πŸ“‰ Group Benefits adjusted earnings increased 25 percent to USD 503 million but missed the mortality ratio target of 83-88 percent.

πŸš€ Piper Sandler upgraded MetLife to Overweight and raised its price target from USD 99.00 to USD 110.00.

πŸ“Š Stock reached USD 101.01 on October 13, 2026, following the positive earnings and buyback news.

πŸ’Έ MetLife has returned over USD 2.4 billion to shareholders via buybacks and dividends through July 2026.

πŸ“… Third-quarter results are scheduled for November 4, 2026, focusing on investment income volatility.

🏒 Market capitalization stands at USD 63.3 billion as of October 19, 2026.

Bullish Signals
  • MetLife adjusted earnings rose 15 percent to USD 1.6 billion in Q2 2026, with EPS up 20 percent year over year.
  • The company authorized a new USD 3 billion share repurchase program on October 9, 2026.
  • Piper Sandler upgraded MetLife to Overweight and raised its price target from USD 99.00 to USD 110.00.
  • Stock reached USD 101.01 on October 13, 2026, following the positive earnings and buyback news.
  • MetLife has returned over USD 2.4 billion to shareholders via buybacks and dividends through July 2026.
Risk Factors
  • Group Benefits mortality ratio was 79 percent, which remains below the company's targeted range of 83 percent to 88 percent for 2026.
  • The upcoming Q3 report will need to test whether favorable underwriting trends can offset typical investment income volatility.
Full Analysis
MetLife Inc. reported a strong second quarter in 2026, with adjusted earnings rising 15 percent to USD 1.6 billion and adjusted earnings per share increasing 20 percent year over year to USD 2.43. The company also announced a new authorization for USD 3 billion in share repurchases, signaling confidence in its financial position and commitment to returning capital to shareholders. Group Benefits emerged as the primary operating driver during this period, posting adjusted earnings of USD 503 million, a 25 percent increase year over year. However, the segment's mortality ratio was 79 percent, which remains below the company's targeted range of 83 percent to 88 percent for 2026, indicating room for improvement in underwriting performance. Following the earnings release and buyback announcement, MetLife stock reached USD 101.01 on October 13, 2026, after Piper Sandler upgraded the stock to Overweight with a price target increase to USD 110.00. The company is scheduled to report third-quarter results on November 4, 2026, where investors will look for continued underwriting strength to offset potential volatility in investment income. MetLife has returned over USD 2.4 billion to shareholders through buybacks and dividends as of July 2026. With a market capitalization of approximately USD 63.3 billion, the insurer operates within the Financial Services sector, specifically Life Insurance, and continues to navigate the balance between investment income fluctuations and core underwriting profitability.